Atara Biotherapeutics, Inc. (0HIY.L) LSE

17.00

+1.605(+10.43%)

Updated at October 21 09:00AM

Currency In USD

Valuation

Market Cap99.67M
Enterprise Value118.47M
P/E Ratio33.76
PEG Ratio0.38
Price/Sales Ratio0.6
Price/Book Ratio-5.58
Enterprise/Revenue0.59
Enterprise/EBITDA7.77

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.03
Operating Margin0.04

Management Effectiveness

Return On Assets0.16
Return On Equity-0.08

Income Statement

Revenue128.94M
Revenue/Share15.47
Gross Profit107.93M
EBITDA-75.75M
Net Income-85.4M
Diluted EPS-11.41

Balance Sheet

Total Cash22.32M
Total Cash/Share1.83
Total Debt15.43M
Total Debt/Equity-0.44
Current Ratio1.7
Book Value Per Share-2.87

Price History

52-Week Change88.47
52-Week High17
52-Week Low0.2
Moving Average 50 Days0.72
Moving Average 200 Days1.3

Statistics

Average Volume52,102
Shares Outstanding7.02M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:25
Last Split DateJune 20, 2024